Research members at the UArizona Cancer Center collaborated in a phase 2 clinical trial that is the first to show the feasibility and acceptability of immunotherapy for prostate cancer in patients on active surveillance.

COVID-19 was the third-leading cause of death in 2020 and 2021 behind heart disease and cancer, Arizona data shows, but some health experts say that isn't telling the full story of its lethal effects in the state.

Arizona is seeing more influenza cases than the state has ever recorded this early in the season.

The Center for Advanced Molecular and Immunological Therapies, impactful research studies and a visit from first lady Jill Biden made headlines at the University of Arizona Health Sciences in 2022.

According to two related studies presented at the Radiological Society of North America 2022 Annual Meeting, corticosteroid injections may worsen progression of knee osteoarthritis and injecting hyaluronic acid instead, or managing the condition without injections, may better preserve knee structure and cartilage.

Reiki, a form of energy healing that originated in Japan in the early 20th century, heals by flowing through the affected parts of the energy field and charging them with positive energy.

Over the last 160 years, bishops from the Catholic church have recognized 70 medical miracles connected to The Sanctuary of Our Lady of Lourdes in southern France, which attracts more than 3 million pilgrims annually.

The UArizona Cancer Engineering Initiative, a collaboration between the UArizona Cancer Center and the College of Engineering, received $10.8 million in New Economy Initiative funding to create humanlike cancer models and growth environments to help improve prevention, diagnosis and treatment.

John R. P. Tesser, MD, clinical lecturer at the UArizona College of Medicine – Tucson, reflects on his career as a rheumatologist.

New findings from a meta-analysis of 13 independent studies published in the Journal of Clinical Endocrinology & Metabolism showed the strong real-world performance of the Afirma Genomic Sequencing Classifier.